TIM-3 Dictates Functional Orientation of the Immune Infiltrate in Ovarian Cancer

0505520 - ÚI 2020 US eng J - Článek v odborném periodiku
Fučíková, J. - Raková, J. - Hensler, M. - Kašíková, L. - Belicová, L. - Hladíková, K. - Truxová, I. - Skapa, P. - Laco, J. - Pecen, Ladislav - Práznovec, I. - Halaška, M. - Brtnický, T. - Kodet, R. - Fialová, A. - Pineau, J. - Gey, A. - Tartour, E. - Ryška, A. - Galluzzi, L. - Špíšek, R.
TIM-3 Dictates Functional Orientation of the Immune Infiltrate in Ovarian Cancer.
Clinical Cancer Research. Roč. 25, č. 15 (2019), s. 4820-4831. ISSN 1078-0432. E-ISSN 1557-3265
Impakt faktor: 10.107, rok: 2019

Citováno: 15

--- WU, J.L. - ZHAO, J. - ZHANG, H.B. - ZUO, W.W. - LI, Y. - KANG, S. Genetic variants and expression of the TIM-3 gene are associated with clinical prognosis in patients with epithelial ovarian cancer. GYNECOLOGIC ONCOLOGY. ISSN 0090-8258, OCT 2020, vol. 159, no. 1, p. 270-276. [WOS]
--- MANFREDI, F. - CIANCIOTTI, B.C. - POTENZA, A. - TASSI, E. - NOVIELLO, M. - BIONDI, A. - CICERI, F. - BONINI, C. - RUGGIERO, E. TCR Redirected T Cells for Cancer Treatment: Achievements, Hurdles, and Goals. FRONTIERS IN IMMUNOLOGY. ISSN 1664-3224, SEP 3 2020, vol. 11. [WOS]
--- GALLUZZI, L. - HUMEAU, J. - BUQUE, A. - ZITVOGEL, L. - KROEMER, G. Immunostimulation with chemotherapy in the era of immune checkpoint inhibitors. NATURE REVIEWS CLINICAL ONCOLOGY. ISSN 1759-4774. [WOS]
--- LIU, Z.R. - WU, H.F. - DENG, J.C. - WANG, H.Q. - WANG, Z.X. - YANG, A.L. - LIANG, B.W. - LUO, J. - LI, J.Y. - XU, Y.M. - TANG, X.L. - FU, F. - DENG, L.B. Molecular classification and immunologic characteristics of immunoreactive high-grade serous ovarian cancer. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE. ISSN 1582-1838. [WOS]
--- KUAI, W.T. - XU, X.J. - YAN, J. - ZHAO, W.J. - LI, Y.X. - WANG, B. - YUAN, N. - LI, Z.X. - JIA, Y.T. Prognostic Impact of PD-1 and Tim-3 Expression in Tumor Tissue in Stage I-III Colorectal Cancer. BIOMED RESEARCH INTERNATIONAL. ISSN 2314-6133, MAY 14 2020, vol. 2020. [WOS]
--- DENG, S.S. - SUN, Z.C. - QIAO, J. - LIANG, Y. - LIU, L.C. - DONG, C.B. - SHEN, A.J. - WANG, Y. - TANG, H. - FU, Y.X. - PENG, H. Targeting tumors with IL-21 reshapes the tumor microenvironment by proliferating PD-1(int)Tim-3(-)CD8(+) T cells. JCI INSIGHT. APR 9 2020, vol. 5, no. 7. [WOS]
--- MORIMOTO, K. - MORIMOTO, Y. - UCHINO, J. Can the assessment of lymphocyte exhaustion serve as a prognostic predictor after lung cancer surgery?. TRANSLATIONAL LUNG CANCER RESEARCH. ISSN 2218-6751, APR 2020, vol. 9, no. 2, p. 184-187. [WOS]
--- LE SAUX, O. - DUBOIS, B. - STERN, M.H. - TERME, M. - TARTOUR, E. - CLASSE, J.M. - CHOPIN, N. - TREDAN, O. - CAUX, C. - RAY-COQUARD, I. Current advances in immunotherapy in ovarian cancer. BULLETIN DU CANCER. ISSN 0007-4551, APR 2020, vol. 107, no. 4, p. 465-473. [WOS]
--- PICARD, E. - VERSCHOOR, C.P. - MA, G.C.W. - PAWELEC, G. Relationships Between Immune Landscapes, Genetic Subtypes and Responses to Immunotherapy in Colorectal Cancer. FRONTIERS IN IMMUNOLOGY. ISSN 1664-3224, MAR 6 2020, vol. 11. [WOS]
--- DE GUILLEBON, E. - DARDENNE, A. - SALDMANN, A. - SEGUIER, S. - TRAN, T. - PAOLINI, L. - LEBBE, C. - TARTOUR, E. Beyond the concept of cold and hot tumors for the development of novel predictive biomarkers and the rational design of immunotherapy combination. INTERNATIONAL JOURNAL OF CANCER. ISSN 0020-7136, SEP 15 2020, vol. 147, no. 6, p. 1509-1518. [WOS]
--- ZHANG, G.D. - LU, J.Q. - YANG, M.R. - WANG, Y.Y. - LIU, H.O. - XU, C.J. Elevated GALNT10 expression identifies immunosuppressive microenvironment and dismal prognosis of patients with high grade serous ovarian cancer. CANCER IMMUNOLOGY IMMUNOTHERAPY. ISSN 0340-7004, FEB 2020, vol. 69, no. 2, p. 175-187. [WOS]
--- ZENG, H. - ZHOU, Q. - WANG, Z.W. - ZHANG, H.Y. - LIU, Z.P. - HUANG, Q.R. - WANG, J.J. - CHANG, Y. - BAI, Q. - XIA, Y. - WANG, Y.W. - XU, L. - DAI, B. - GUO, J.M. - LIU, L. - ZHU, Y. - XU, J.J. Stromal LAG-3(+)cells infiltration defines poor prognosis subtype muscle-invasive bladder cancer with immunoevasive contexture. JOURNAL FOR IMMUNOTHERAPY OF CANCER. 2020, vol. 8, no. 1. [WOS]
--- YAMAZAKI, T. - BUQUE, A. - AMES, T.D. - GALLUZZI, L. PT-112 induces immunogenic cell death and synergizes with immune checkpoint blockers in mouse tumor models. ONCOIMMUNOLOGY. ISSN 2162-402X, 2020, vol. 9, no. 1. [WOS]
--- TU, L. - GUAN, R.G. - YANG, H.T. - ZHOU, Y. - HONG, W.F. - MA, L.H. - ZHAO, G.Z. - YU, M. Assessment of the expression of the immune checkpoint molecules PD-1, CTLA4, TIM-3 and LAG-3 across different cancers in relation to treatment response, tumor-infiltrating immune cells and survival. INTERNATIONAL JOURNAL OF CANCER. ISSN 0020-7136, JUL 15 2020, vol. 147, no. 2, p. 423-439. [WOS]
--- JIA, K.Y. - HE, Y.Y. - DZIADZIUSZKO, R. - ZHAO, S. - ZHANG, X.S. - DENG, J. - WANG, H. - HIRSCH, F.R. - ZHOU, C.C. - YU, H. - ZHANG, L.P. T cell immunoglobulin and mucin-domain containing-3 in non-small cell lung cancer. TRANSLATIONAL LUNG CANCER RESEARCH. ISSN 2218-6751, DEC 2019, vol. 8, no. 6, p. 895-+. [WOS]

Trvalý link: http://hdl.handle.net/11104/0297003